Alexander Tatem, MD
Urology · Carmel, INNPI 1114364064
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $259,604 of the $418,070 with a category attached, or 62.1%. Boston Scientific accounts for 62.0% of it on its own, with 43 other manufacturers making up the rest. Among urology clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,022 payments — averaging $409.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$259K
- Endo Pharmaceuticals Inc.$78K
- Endo USA, Inc.$26K
- Central Indiana URS Consumables, LLC$22K
- Coloplast$21K
- Marius Pharmaceuticals, Inc$8K
- plus $4K from 38 others
Across 2 payments — averaging $3887.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Endo USA, Inc.$8K
Across 2 payments — averaging $7800.00 each. An ownership or investment interest held by the physician or an immediate family member.
- Central Indiana URS Consumables, LLC$16K
What the payments were for
- Consulting fees$60,51314%
- Speaking & faculty fees$259,60462%
- Travel & lodging$36,8389%
- Food & beverage$28,6697%
- Education$10,3762%
- Other$22,0715%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TACTRA$131,175
- XIAFLEX$101,659
- Dornier MedTech$88,286
- AdVance XP$36,553
- CVAC Aspiration System$22,071
- GENERAL ERECTILE DYSFUNCTION$20,955
- TITAN$17,841
- AMS$16,770
- AMS 700 CXR RTE KIT$8,299
- AMS 700$5,132
- GENERAL - THERAPIES$4,018
- ADVANCE$2,711
- PENILE & TESTICULAR RECONSTRUCTN$880
- EDEX$262
- AVEED$111
- 09 PROMO FLEX-X FLEX URETEROSCOPE, 7.5F$111
How this compares
$418,070 in reported general payments places this provider in the 95th percentile of 272 urology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 179 | $5,136 |
| Cabergoline | 19 | $1,861 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 174 | $807 |
| Testosterone Cypionate | 13 | $608 |
| Gabapentin | 196 | $441 |
| Anastrozole | 36 | $268 |
| Ciprofloxacin Hcl | 19 | $125 |
| Doxycycline Hyclate | 19 | $120 |
| Sildenafil Citrate | 11 | $119 |
| Tamsulosin Hcl | 14 | $101 |
| Clindamycin Hcl | 12 | $49 |
Paid to pharmacies, not to this prescriber.
Other urology in Carmel
- Chad ReichardCarmel$400K
- Matthew MellonCarmel$159K
- Jason KovacCarmel$112K
- Kenneth NeyCarmel$55K
- Jeremiah DallmerCarmel$52K
- Scott FarnhamCarmel$30K
- Megan BockCarmel$28K
- Joshua RingCarmel$13K
- Clinton BahlerCarmel$11K
- Scott PikeCarmel$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.